Lightly Regulated In Vitro Fertilization Yields Thousands of Babies Annually
By Michael Ollove,
The Washington Post
| 04. 13. 2015
[Quotes CGS's Marcy Darnovsky]
Untitled Document
If in vitro fertilization still seems to be cutting-edge medicine, you haven’t been paying attention.
The first infant born in the United States as a result of in vitro fertilization entered the world in 1981. In 2012, according to the Centers for Disease Control and Prevention, more than 65,000 U.S. births resulted from assisted reproduction technology. (ART generally refers to fertility treatments in which either eggs or embryos are handled, but it does not include artificial insemination, which experts believe results in far more births than ART does.) The CDC also reports that about 12 percent of women of childbearing age have used infertility services and that 1.5 percent of all American infants are conceived using ART.
So, assisted reproduction is nothing new. And yet regarding regulatory matters, both the federal government and the states have given the multi-billion-dollar industry a wide berth, which makes this country very much an outlier compared with the rest of the developed world. (One exception to minimal federal intervention: President George W. Bush’s ban in 2001 on the use of newly...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...